MARY LOUISE CHAMBERLAIN

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant DENVER, CO NPI 1487112876

General Payments — all program years on this page

$1,008.83

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 42
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $877.47 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $877.4739

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $34.232
2022 $97.131
2024 $877.4739

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1084835462 Noven Therapeutics, LLC $19.18 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101576504 E.R. Squibb & Sons, L.L.C. $17.97 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106899394 ABBVIE INC. $24.23 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106899396 ABBVIE INC. $14.17 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106899398 ABBVIE INC. $28.26 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106899400 ABBVIE INC. $31.23 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106899402 ABBVIE INC. $34.33 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106899404 ABBVIE INC. $23.34 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106899406 ABBVIE INC. $28.71 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106899408 ABBVIE INC. $10.58 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119042829 Otsuka America Pharmaceutical, Inc. $17.89 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119042831 Otsuka America Pharmaceutical, Inc. $21.06 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119042833 Otsuka America Pharmaceutical, Inc. $15.61 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119042835 Otsuka America Pharmaceutical, Inc. $22.03 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119042837 Otsuka America Pharmaceutical, Inc. $17.66 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120477768 Alkermes, Inc. $26.10 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120477770 Alkermes, Inc. $18.10 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137724294 Takeda Pharmaceuticals U.S.A., Inc. $18.26 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137724296 Takeda Pharmaceuticals U.S.A., Inc. $22.83 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137724298 Takeda Pharmaceuticals U.S.A., Inc. $21.88 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137724300 Takeda Pharmaceuticals U.S.A., Inc. $24.87 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143402167 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.69 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143402170 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.05 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143402173 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.56 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143402177 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.49 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146774438 IDORSIA PHARMACEUTICALS US INC $16.22 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147236941 Tris Pharma Inc $59.57 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150179499 Tempus AI, Inc $13.45 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150179501 Tempus AI, Inc $20.90 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150933646 Neurocrine Biosciences, Inc. $33.51 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150942373 Neurocrine Biosciences, Inc. $28.91 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150959662 Neurocrine Biosciences, Inc. $23.91 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150971853 Neurocrine Biosciences, Inc. $21.59 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150991266 Neurocrine Biosciences, Inc. $17.73 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151564706 Teva Pharmaceuticals USA, Inc. $21.89 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151564726 Teva Pharmaceuticals USA, Inc. $22.23 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151564746 Teva Pharmaceuticals USA, Inc. $19.08 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151564790 Teva Pharmaceuticals USA, Inc. $20.79 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151564798 Teva Pharmaceuticals USA, Inc. $22.61 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.